1.11
Tscan Therapeutics Inc Borsa (TCRX) Ultime notizie
How TScan Therapeutics Inc. stock reacts to oil pricesJuly 2025 Reactions & Community Driven Trade Alerts - moha.gov.vn
Is TScan Therapeutics Inc a good long term investmentStock Liquidity Analysis & Free Tools to Find Winning Stocks - earlytimes.in
Is TScan Therapeutics Inc. stock dividend yield sustainableTrade Exit Report & Daily Technical Stock Forecast Reports - moha.gov.vn
TScan Therapeutics Approves Key Employee Retention Program - TipRanks
[8-K] TScan Therapeutics, Inc. Reports Material Event | TCRX SEC FilingForm 8-K - Stock Titan
Cluey Ltd Launches $4.5 Million Entitlement Offer - The Globe and Mail
Tscan Therapeutics Inc (TCRX) is looking forward to a strong quarter - Setenews
Reversal indicators forming on TScan Therapeutics Inc. stockProfit Target & Consistent Profit Alerts - newser.com
Is TScan Therapeutics Inc. stock positioned well for digital economyTrade Ideas & Daily Oversold Bounce Ideas - newser.com
Applying chart zones and confluence areas to TScan Therapeutics Inc.2025 Pullback Review & Reliable Price Breakout Alerts - newser.com
Is TScan Therapeutics Inc. building a consolidation baseJuly 2025 Closing Moves & Safe Capital Growth Stock Tips - newser.com
How TScan Therapeutics Inc. stock performs in high volatility markets2025 Market Outlook & Expert Curated Trade Setups - newser.com
TScan Therapeutics (NASDAQ:TCRX) Cut to Equal Weight at Morgan Stanley - Defense World
Equities Analysts Issue Forecasts for TCRX FY2025 Earnings - Defense World
Best data tools to analyze TScan Therapeutics Inc. stockJuly 2025 Macro Moves & Daily Growth Stock Tips - newser.com
How TScan Therapeutics Inc. stock reacts to global recession fears2025 Major Catalysts & Growth Oriented Trading Recommendations - newser.com
HC Wainwright Cuts TScan Therapeutics (NASDAQ:TCRX) Price Target to $7.00 - Defense World
Should you wait for a breakout in TScan Therapeutics Inc.Weekly Risk Summary & Scalable Portfolio Growth Methods - newser.com
How TScan Therapeutics Inc. stock performs in rate cut cyclesWeekly Trade Review & Real-Time Stock Movement Alerts - newser.com
Using data filters to optimize entry into TScan Therapeutics Inc.2025 Earnings Impact & Technical Pattern Recognition Alerts - newser.com
Morgan Stanley Downgrades TScan Therapeutics to Equalweight From Overweight - MarketScreener
Morgan Stanley downgrades Tscan Therapeutics stock on delayed trials By Investing.com - Investing.com Canada
Morgan Stanley downgrades Tscan Therapeutics stock on delayed trials - Investing.com India
HC Wainwright & Co. Maintains TScan Therapeutics (TCRX) Buy Recommendation - Nasdaq
Is TScan Therapeutics Inc. still worth holding after the dipQuarterly Investment Review & Weekly Breakout Stock Alerts - newser.com
Technical signs of recovery in TScan Therapeutics Inc.Weekly Market Outlook & Accurate Technical Buy Alerts - newser.com
TScan Therapeutics Draws Analyst Optimism Despite Growing Losses - Finimize
Applying sector rotation models to TScan Therapeutics Inc.Quarterly Portfolio Summary & Low Volatility Stock Recommendations - newser.com
TScan Therapeutics Reports Increased Revenue Amid Rising Losses - The Globe and Mail
TScan Therapeutics, Inc. (TCRX) Reports Q3 Loss, Lags Revenue Estimates - sharewise.com
Published on: 2025-11-12 17:29:17 - newser.com
Tscan Therapeutics earnings beat by $0.06, revenue topped estimates - Investing.com Canada
What technical models suggest about TScan Therapeutics Inc.’s comebackWeekly Investment Report & Community Trade Idea Sharing - newser.com
TScan Therapeutics, Inc. Q3 Loss Increases, But Beats Estimates - Nasdaq
TScan Therapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025 - MarketScreener
TScan Therapeutics Q3 revenue jumps - MarketScreener
TScan Therapeutics Reports Third Quarter 2025 Financial Results and Provides Corporate Update - The Manila Times
TScan (NASDAQ: TCRX) secures FDA agreement on TSC-101 pivotal design; runway to 2027 - Stock Titan
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):